News & Events about Gh Research Plc.
Globe Newswire
3 months ago
DUBLIN, Ireland, March 02, 2023 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today reported financial results for the full year ended December 31, 2022 and gave ...
Globe Newswire
5 months ago
Initial approvals received for Phase 2b trial of GH001 in TRD (GH001-TRD-201), initiation of this trial expected in Q1 2023Development of proprietary aerosol delivery device for GH001 progressed, IND submission with this device expected in Q3 2023Phase 1 trial of GH002 in healthy volunteers (GH002-...
Ticker Report
8 months ago
Exchange Traded Concepts LLC lifted its holdings in shares of GH Research PLC (NASDAQ:GHRS Get Rating) by 373.4% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,885 shares of the companys stock after acquiring an ...
Psychedelic Therapies Offer Hope for Mental Health Psychedelic Therapies Offer Hope for Mental Health NetworkNewsWire Editorial Coverage PR Newswire NEW YORK, March 2, 2022 NEW YORK, March 2, 2022 /PRNewswire/ -- Neural plasticity is instrumental in brain health, and the importance of...